Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

B. Newman, Connie; Preiss, David; A. Tobert, Jonathan; A. Jacobson, Terry; L. Page, Robert; B. Goldstein, Larry; Chin, Clifford; R. Tannock, Lisa; Miller, Michael; Raghuveer, Geetha; Barton Duell, P.; A. Brinton, Eliot; W. Pollak, Amy; T. Braun, Lynne; K. Welty, Francine

doi:10.1161/atv.0000000000000073

Public

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

Published in Arteriosclerosis Thrombosis and Vascular Biology • Jan 17, 2019

Authors:

Connie B. Newman

David Preiss

Jonathan A. Tobert

Abstract

One in 4 Americans >40 years of age takes a statin to reduce the risk of myocardial infarction, ischemic stroke, and other complications of atherosclerotic disease. The most effective statins produce a mean reduction in low-density lipoprotein cholesterol of 55% to 60% at the maximum dosage, and 6 o...

Subject

Medicine

Statin

Stroke (engine)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!